Located in the prestigious SAHMRI building in Adelaide, SAGC is a nationally accredited genomics facility that supports research nationally and internation...
The grant has been awarded by the Australian Government's National Health and Medical Research Council (NHMRC), and will be matched by the South Australian...
Dedicaid's core asset is a clinical decision support software (CDSS) AI platform capable of rapidly generating indication-specific CDSS applications from a...
-AmerisourceBergen, a global healthcare company, today announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integr...
The Asia-Pacific Bioprocessing Excellence Awards (ABEA), hosted by IMAPAC, gives recognition to exceptional Asian bioprocessing companies for their achieve...
These new patents complement the company's strong international portfolio of 20 families and more than 78 patents covering the concept, design, production ...
Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform compa...
Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to boos...
Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and manufacturi...
Recorded Q1'23 consolidated revenue of KRW 720.9 billion. Recorded Q1'23 consolidated operating profit of KRW 191.7 billion. Expected to main...
Revenue Up 5.8% Year-Over-Year to RMB8,964 MillionNet Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year to RMB2,168 MillionDiluted ...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that its QIAstat-Dx syndromic testing solution is expected to be available soon for use ...
Singapore based SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their a...
BBM-H901 is indicated for prophylactic treatment of bleeding in adults with hemophilia B. It is the first adeno-associated virus (AAV) gene therapy for Hem...
© 2024 Biopharma Boardroom. All Rights Reserved.
